Brought to you by 
Boston Scientific to distribute CR Bard's Lutonix in the US
28 Aug 2017
Executive Summary
CR Bard Inc. granted Boston Scientific Corp. rights to distribute its Lutonix 035 drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter in the US.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific to distribute CR Bard's Lutonix in the US
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice